Climate Change Data

Environmental Metrics

ESG Focus Areas

• Environmental
• Social
• Governance

Environmental Achievements

• Strive for all components in Implantica’s products and packaging to be recyclable where possible
• Providing treatments that are safe for both patients and the environment.
• Observe environmental criteria when choosing suppliers
• Lower energy consumption and emission of greenhouse gases in every part of the organization, both during development and manufacturing of components

Social Achievements

• Ensuring patient access to effective treatment by supporting the medical community, working actively with pricing, reimbursement, regulatory approvals and market expansion.
• Acting responsibly and ethically in all we do through high research standards, business ethics and policies aimed at creating a sustainable organization purposed to serve the community.

Governance Achievements

• Optimized board composition through appointment of new chairman
• Furthered board optimization with highly experienced Tomas Puusepp joining the Implantica board.

Climate Goals & Targets

Environmental Challenges

• Covid-19 created a problem for surgeries and sales representative engagement with hospital staff.
• The by far most complicated countries to achieve reimbursement in are France and Austria, where an additional randomized clinical trial is needed.

Mitigation Strategies

• Surgical webinars were launched to facilitate surgeon outreach and training during Covid-19.
• Educational Webinars, virtual lectures were organized to expand the knowledge about RefluxStopTM among surgeons, hospitals and payers.
• The French Health Ministry (HAS) has a system called “forfeit innovation” which provides funding for a randomized trial in France.

Supply Chain Management

Responsible Procurement

• Observe environmental criteria when choosing suppliers

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI

Sustainable Products & Innovation

• RefluxStop™
• UriControl®
• AppetiteControl™
• UriRestore™
• StomaRestore®
• PotencyFlow®
• RectalRestore®

Environmental Metrics

ESG Focus Areas

• Good Health and Well-being

Social Achievements

• Established a new competent organization by recruiting more than 20 super competent and motivated personnel.
• Implemented an extensive onboarding process to build a strong company culture.

Climate Goals & Targets

Environmental Challenges

• COVID-19 pandemic affected elective surgeries and caused delays in market access and product development.
• Shortage of electronic components, especially miniaturized chips, delayed the timeline of smart medical implants.
• Missed the deadline for UriControl® approval due to changes in the European approval system from MDD to MDR.

Mitigation Strategies

• Incorporated a wholly owned subsidiary in the US (Implantica Inc.) in preparation for US market entry.
• Developed a robust market access strategy, including a commercial development team.
• Commissioned a real-world observational registry study and planned a large multinational Randomized Controlled Study to meet reimbursement requirements.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: GRI

UN Sustainable Development Goals

• Goal 3

Implantica's mission to provide medical implant solutions contributes to the UN's Global Sustainable Development Goal "Good Health and Well-being".